Review of guideline for the management of ANCA-associated vasculitis, presented in 2021 by the American College of Rheumatology/Vasculitis Foundation
Open Access
- 27 December 2021
- journal article
- review article
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 59 (6) , 684-692
Abstract
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of severe life-threatening autoimmune diseases, and one of the most important problems in practical rheumatology. This article discusses 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of AAVs, including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA). The guideline features 26 recommendations and 5 upgraded position statements for GPA/ MPA, as well as 15 recommendations and 5 upgraded position statements for EGPA, which became the basis for the proposed algorithms for the treatment of patients with GPA/MPA and EGPA. Particular attention has been paid to the use of biologics.Keywords
This publication has 29 references indexed in Scilit:
- Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysisRheumatology, 2011
- Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multicenter ExperienceTransplantation, 2011
- The Five-Factor Score RevisitedMedicine, 2011
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal VasculitisNew England Journal of Medicine, 2010
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisNew England Journal of Medicine, 2010
- Azathioprine or Methotrexate Maintenance for ANCA-Associated VasculitisNew England Journal of Medicine, 2008
- Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal VasculitisJournal of the American Society of Nephrology, 2007
- Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosisRheumatology, 2007
- Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitisArthritis & Rheumatism, 2005
- Long‐Term Follow‐up of Repair of External Nasal Deformities in Patients With Wegener's GranulomatosisThe Laryngoscope, 2002